ACAD 241220 16.00P (ACAD241220P16000) Stock Options, News & Quotes

US OptionsDetailed Quotes

ACAD241220P16000

Watchlist

0.50
-0.25-33.33%

15min DelayClose Nov 25 16:00 ET

0.51High0.45Low

Intraday

5D
Daily

News

Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
BusinesswireNov 21 16:05 ET
CCORF Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Maintains Target Price $32
Moomoo NewsNov 21 07:31 ET · Ratings
ACADIA Pharmaceuticals: Strategic Leadership and Growth Prospects Support Buy Rating
TipRanksNov 21 06:55 ET · Ratings
Acadia Pharmaceuticals Announces Leadership Change Amid COO Departure
TipRanksNov 20 16:55 ET
Express News | ACADIA Pharmaceuticals Inc - on Nov 18, Co Involuntarily Terminates COO Brendan Teehan
ReutersNov 20 16:34 ET
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BusinesswireNov 15 16:05 ET

Comments

Trytosaveabit

Nov 5 15:06

News

$ACADIA Pharmaceuticals (ACAD.US)$ Reuters· just
ACADIA Pharmaceuticals Enters Into an Agreement to Sell Its Rare Pediatric Disease Priority Review Voucher for $150 Million

Meltyy

May 16 01:14

🔔 Baker Bros. Q1 ‘24* Holdings Released... 🐳

» Holdings: 87
» Holdings in Top 20: 86.71%
» Qtr over Qtr Change**: -9.29%
Top Holdings:
$Incyte (INCY.US)$
$BeiGene (BGNE.US)$
$ACADIA Pharmaceuticals (ACAD.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Revolution Medicines (RVMD.US)$
$Kymera Therapeutics (KYMR.US)$
$AbCellera Biologics (ABCL.US)$
$Bicycle Therapeutics (BCYC.US)$
$Edgewise Therapeutics (EWTX.US)$
$Immunocore (IMCR.US)$
$Kodiak Sciences (KOD.US)$
$Roivant Sciences (ROIV.US)$
...

Moomoo AI

Mar 27 13:28

Analysts have high confidence in ACADIA Pharmaceuticals, predicting an average annual growth rate of 42%. The company's lack of debt reduces concerns around repayments and makes it a less risky investment.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) On The Verge Of Breaking Even

SOARMAN

Mar 12 04:47

Several companies were in the spotlight due to various developments:
Oracle ( $Oracle (ORCL.US)$ ) experienced a surge in after-hours trading, buoyed by cloud deals and AI demand.
Acadia Pharmaceuticals ( $ACADIA Pharmaceuticals (ACAD.US)$ ) saw its stock decline by 15% following the announcement of disappointing results from a Phase 3 trial.
Vail Resorts ( $Vail Resorts (MTN.US)$ ) reported a decrease in stock value after releasing results that were impacted by lower visits and snowfall.
$Asana (ASAN.US)$ Asana rep...

Trytosaveabit

Mar 11 15:37

$ACADIA Pharmaceuticals (ACAD.US)$ And where will the bottom be? Could it be a opportunity? Time will tell? Hehehe